Zacks Investment Research
06 Aug 2026, 16:46 UTC · 1h ago
Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
06 Aug 2026, 16:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Intuitive Surgical's da Vinci 5 platform is initiating a multi-year capital upgrade cycle characterized by rapid physician adoption and accelerating trade-ins. — A sustained, multi-year upgrade cycle suggests long-term revenue growth and high demand for the company's core hardware.
+0.60The da Vinci 5 is designed as a software-enabled platform with over 100 planned updates and ongoing FDA 510(k) submissions for new features. — Shifting from hardware-centric to software-driven updates creates a recurring value proposition and extends the competitive moat.
+0.40U.S. capital spending remains stable, with leasing accounting for approximately 70% of U.S. system acquisitions. — High leasing penetration mitigates the impact of macroeconomic headwinds on hospital capital budgets.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
Strong Q2 2026 results and rapid adoption of the da Vinci 5 platform indicate a multi-year growth cycle.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
